Related references
Note: Only part of the references are listed.High expression of CMTM6 is a risk factor for poor prognosis of gastrointestinal tumors: A meta-analysis
Mengjie Dai et al.
ASIAN JOURNAL OF SURGERY (2023)
Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
Cheng Lin et al.
BMC GENOMICS (2023)
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Y. Tao et al.
ANNALS OF ONCOLOGY (2023)
Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma
Hirotaka Shinomiya et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2023)
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
Amelie von Bernuth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Role of tumor microenvironment in cancer progression and therapeutic strategy
Qingjing Wang et al.
CANCER MEDICINE (2023)
Inflammatory response-related genes predict prognosis in patients with HNSCC
Si-li Jing et al.
IMMUNOLOGY LETTERS (2023)
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
Friederike Hoffmann et al.
Clinical Epigenetics (2023)
Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France
Sophie Deneuve et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
CMTM6, a potential immunotherapy target
Jie Liang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer
Lynette M. Sholl
MODERN PATHOLOGY (2022)
Prognostic potential of Akt, pAkt(Ser473) and pAkt(Thr308) immunoreactivity in relation to HPV prevalence in head and neck squamous cell carcinoma patients
Anna Janecka-Widla et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer
Bo Yin et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma
Zhonghua Liu et al.
CANCER CYTOPATHOLOGY (2022)
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?
James E. Bates et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Yue Huang et al.
CELL DEATH & DISEASE (2022)
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
Luise Klapper et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020
Valentina Lorenzoni et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)
CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis
Pallavi Mohapatra et al.
FASEB JOURNAL (2022)
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy
Hanbing Wang et al.
CANCER LETTERS (2021)
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
Kenneth Emancipator et al.
MODERN PATHOLOGY (2021)
Immune Cell Landscape in Gastric Cancer
Yang Yang et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
Yanbin Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
Immunologic Cold Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
Julika Ribbat-Idel et al.
FRONTIERS IN MEDICINE (2021)
Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
Chao Zhang et al.
CANCER CELL INTERNATIONAL (2021)
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer
Qi-Hua Peng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
Vito Amodio et al.
CANCERS (2021)
OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway
Xin Pang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
Lei Chen et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study
Yujiao Deng et al.
AGING-US (2020)
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study
Viktor Gruenwald et al.
ORAL ONCOLOGY (2020)
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas
Mario Sanchez-Canteli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Identifying predictors ofHPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models
Nicole D. Facompre et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
P16 expression and its association with PD-L1 expression and FOXP3-positive tumor infiltrating lymphocytes in head and neck squamous cell carcinoma
Taeyeong Kim et al.
MOLECULAR & CELLULAR TOXICOLOGY (2019)
Epidemiology of head and neck cancer in Germany
Antje Wienecke et al.
ONKOLOGE (2019)
Infiltration of FoxP3+Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
Imelda Seminerio et al.
CANCERS (2019)
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
T. Eder et al.
EUROPEAN JOURNAL OF CANCER (2019)
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
Nabil F. Saba et al.
ORAL ONCOLOGY (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer
Jon Zugazagoitia et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
Emma J. de Ruiter et al.
ONCOIMMUNOLOGY (2017)
Akt2 and p-Akt overexpression in oral cancer cells is due to a reduced rate of protein degradation
Prakasit Archewa et al.
JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (2017)
Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma
Christian Freudlsperger et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma: an immunohistochemical study
Helder Antonio Rebelo Pontes et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)
Analysis of Marker-Defined HNSCC Subpopulations Reveals a Dynamic Regulation of Tumor Initiating Properties
Paloma Bragado et al.
PLOS ONE (2012)